Alan B. Miller

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed et al. · The Lancet · 2018 · 1.7K citations · Full text

Diabetes Management, Cardiovascular Disease, Diabetes +6

Effect of Amlodipine on Morbidity and Mortality in Severe Chronic Heart Failure

Milton Packer, Christopher M. O’Connor, Jalal K. Ghali et al. · New England Journal of Medicine · 1996 · 1.2K citations · Full text

3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial

Carel W. le Roux, Arne Astrup, Ken Fujioka et al. · The Lancet · 2017 · 813 citations

Obesity, Metabolic Syndrome, Nutrition +8

Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection Fraction

Milton Packer, Stefan D. Anker, Javed Butler et al. · Circulation · 2020 · 408 citations · Full text

Diuretic resistance predicts mortality in patients with advanced heart failure

Gerald W. Neuberg, Alan B. Miller, Chris O’Connor et al. · American Heart Journal · 2002 · 368 citations

Heart Failure, Cardiogenic Shock, Cardiovascular Disease +7